Serum levels of IL-17 are elevated in patients with acute gouty arthritis
Highlights: • We first identify IL-17 as a novel biomarker for acute gouty arthritis (AGA) with acute flares. • γδT cells, rather than Th17 cells, are the principal producers of IL-17 in AGA patients during the acute gout flares. • The serum levels of IL-17 are positively correlated with the activity of AGA and IL-1β. Acute gouty arthritis (AGA) is one of the most common forms of auto-inflammatory arthritis. IL-17 is a key proinflammatory cytokine which has been implicated in several autoimmune diseases. However, to date little is known about the role of IL-17 in AGA. In the present study, we show that serum IL-17 levels are significantly elevated in AGA patients early in the onset of symptoms of gout, and decrease gradually as symptoms diminish. Correlation analysis indicated that IL-17 expression is not only positively correlated with disease activity, but is also correlated with serum levels of IL-1β which plays a critical role in the differentiation of IL-17{sup -} γδT cells into IL-17{sup +}γδT cells. Flow cytometry analysis indicated that γδ T cells are a major source of IL-17 production during the early onset of AGA. We therefore identify IL-17 as a potential novel biomarker for AGA and suggest that targeting the γδ T cell/IL-17 immune axis is a potential strategy for treatment of acute flares of AGA.